维普中文期刊产品整合服务
82篇 您的检索式:作者名="SIPAHI I"
    题名 作者 年代 出处 被引量
1Titanium dioxide induced inflammation in the small intestine显示文摘AIM:To investigate the effects of titanium dioxide (TiO2) nanoparticles (NPTiO 2 ) and microparticles (MPTiO 2 ) on the inflammatory response in the small intestine of mice. METHODS: Bl 57/6 male mice received distilled water suspensions containing TiO 2 (100 mg/kg body weight) as NPTiO 2 (66 nm), or MPTiO 2 (260 nm) by gavage for 10 d, once a day; the control group received only distilled water. At the end of the treatment the duodenum, jejunum and ileum were extracted for assessment of cytokines, inflammatory cells and titanium content. The cytokines interleukin (IL)-1b, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, IL-17, IL-23, tumor necrosis factor-α (TNF-α), intracellular interferon-γ (IFN-γ) and transforming growth factor-β (TGF-β) were evaluated by enzyme-linked immunosorbent assay in segments of jejunum and ileum (mucosa and underlying muscular tissue). CD4 + and CD8 + T cells, natural killer cells, and dendritic cells were evaluated in duodenum, jejunum and ileum samples fixed in 10% formalin by immuno-histochemistry. The titanium content was determined by inductively coupled plasma atomic emission spectrometry. RESULTS: We found increased levels of T CD4 + cells (cells/mm 2 ) in duodenum:NP 1240 ± 139.4, MP 1070 ± 154.7 vs 458 ± 50.39 (P < 0.01); jejunum:NP 908.4 ± 130.3, MP 813.8 ± 103.8 vs 526.6 ± 61.43 (P < 0.05); and ileum:NP 818.60 ± 123.0, MP 640.1 ± 32.75 vs 466.9 ± 22.4 (P < 0.05). In comparison to the control group, the groups receiving TiO 2 showed a statistically significant increase in the levels of the inflammatory cytokines IL-12, IL-4, IL-23, TNF-α, IFN-γ and TGF-β. The cytokine production was more pronounced in the ileum (mean ± SE):IL-12: NP 33.98 ± 11.76, MP 74.11 ± 25.65 vs 19.06 ± 3.92 (P < 0.05); IL-4: NP 17.36 ± 9.96, MP 22.94 ± 7.47 vs 2.19 ± 0.65 (P < 0.05); IL-23: NP 157.20 ± 75.80, MP 134.50 ± 38.31 vs 22.34 ± 5.81 (P < 0.05); TNFα: NP 3.71 ± 1.33, MP 5.44 ± 1.67 vs 0.99± 019 (P < 0.05); IFNγ: NP 15.85 ± 9.99, MP 34.08 ± 11.44 vs 2.81 ± 0.69 (P < 0.05); and TGF-β: NP 780.70 ± 318.50, MP 1409.00 ± 502.20 vs 205.50 ± 63.93 (P < 0.05). CONCLUSION:Our findings indicate that TiO2 particles induce a Th1-mediated inflammatory response in the small bowel in mice.Carolina Maciel Nogueira Walter Mendes de Azevedo Maria Lucia Zaidan Dagli Sérgio Hiroshi Toma AndréZonetti de Arruda Leite Maria Laura Lordello Iêda Nishitokukado Carmen Lúcia Ortiz-Agostinho Maria IrmaSeixas Duarte Marcelo Alves Ferreira Aytan Miranda Sipahi 2012World Journal of Gastroenterology2012,18,34:8
2β-blockers and progression of coronary atherosclerosis:pooled analysis of 4 intravascular ultrasonography trials显示文摘Sipahi I Tuzcu EM Wolski KE 2007Ann Intern Med2007,147,1:1
3Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials显示文摘Nicholls S J Tuzcu E M Kalidindi S Wolski K Moon K W Sipahi I 2008J Am Coll Cardiol2008,52,:1
4Angiotensin-receptor blockade and risk of cancer:meta-analysis of randomised controlled trials显示文摘Sipahi I Debarme SM Rowland DY 2010Lancet Oncol2010,11,7:1
5Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial显示文摘Sipahi I Tuzcu E M Sehoenhagen P 2006Eur Heart J2006,27,14:1
6Effect of very high-intensity statin therapy on regression of coronary atherosclerosis:the ASTEROID trial显示文摘Nissen SE Nicholls SJ sipahi I 2010JAMA2010,295,13:1
7Effect of antihyper- tensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a recta-analysis of randomized controlled trials显示文摘Sipahi I Swaminathan A Natesan V 2012Stroke2012,43,2:1
8Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano 显示文摘Nicholls S J Tuzcu E M Sipahi I 2006J Am Coll Cardiol2006,47,5:1
9Angiotensin- receptor blockade and risk of cancer: meta-analysis of randomised controlled trials显示文摘SIPAHI I DEBANNE S M ROWLAND D Y 2010Lancet Oncol2010,11,7:1
10Angiotensin-receptor blockade and risk of cancer:meta-analysis of randomized controlled trials显示文摘Sipahi I Debanne SM Rowland DY 0,,:1
11Effect of very high-intensity statin therapy on regression of coronary atherosclerosis显示文摘 Nicholls SJ Sipahi I 2006JAMA2006,295,:1
12Emerging role of intravascular ultrasound in the assess ment of experimental anti-athero-sclerotic therapies显示文摘Nicholls SJ Sipahi I 2006Current Medicinal Chemistry2006,13,:1
13Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy:meta-analysis of randomized controlled trials显示文摘Sipahi I Chou JC Hyden M 2012Am Heart J2012,163,:1
14Intravascular ultrasound in the cur rent percutaneous coronary intervention era显示文摘Sipahi I NichollsSJ Tuzcu EM 2006ardiol C1in2006,24,2:1
15Splenic angiomatoid nodular transformation in a child with increased erythrocyte sedimentation rate显示文摘Kuybulu A Sipahi T Topal I 0,,07:1
16Static and serial assess ments of coronary arterial remodeling are discordant:an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid I,owering (REVERSAL) trial显示文摘Sipahi I Tuzcu EM Schoenhagen P 2006Am Heart J2006,152,3:1
17Effect of very high-intensity statin therapy on regression of coronary atherosclerosis:the ASTEROID trial显示文摘Nissen S E Nicholls S J Sipahi I Libby P Raichlen J S Ballantyne C M 2006JAMA2006,295,:1
18Rate of progression of coronary atherosclerotic plaque in women显示文摘Nicholls SJ Wolski K Sipahi I 2007J Am Coll cardiol2007,49,14:1
19Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis显示文摘Nicholls S J Tuzcu E M Sipahi I Grasso A W Schoenhagen P Hu T 2007JAMA2007,297,:1
20Paradoxical increase in lumen size during progression of coronary atherosclerosis : observations from the REVER-SAL trial显示文摘Sipahi I Tuzcu EM Schoenhagen P 2006Atherosclerosis2006,189,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费